Personal information

Activities

Collapse all

Works (3)

Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study

Blood Advances
2024-12-11 | Journal article | Author
DOI: 10.1182/bloodadvances.2024014903
Part of ISSN: 2473-9529
Part of ISSN: 2473-9537
Contributors: Evgenii Shumilov; Rebecca Wurm-Kuczera; Andrea Kerkhoff; Meng Wang; Thomas Melchardt; Udo Holtick; Ulrike Bacher; Philipp Staber; Paolo Mazzeo; Corinna Leng et al.
Source: Self-asserted source
Alexander Sebastian Hölscher

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies

Cancers
2024-01-26 | Journal article
DOI: 10.3390/cancers16030532
Contributors: Felicitas Schulz; Paul Jäger; Johanna Tischer; Alessia Fraccaroli; Gesine Bug; Andreas Hausmann; Ben-Niklas Baermann; Patrick Tressin; Alexander Hoelscher; Annika Kasprzak et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.

Clinical epigenetics
2018-01-04 | Journal article
DOI: 10.1186/s13148-017-0434-3
PMID: 29312470
PMC: PMC5755363
Contributors: Hölscher AS; Wolfgang Schulz; Pinkerneil M; Günter Niegisch; Hoffmann MJ
Source: Self-asserted source
Alexander Sebastian Hölscher
How many people are using ORCID?